About Abil Chempharma Private Limited
Data last updated:
Abil Chempharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 18 September 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2002PTC137264. Its GSTIN is 27AAECA1503D1ZE (Maharashtra). The company holds 5 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹27.26 Lakh. It is led by directors including Sanket Jatin Gandhi and Tejas Champaklal Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Wing Lotus Corporate Park, Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹795.2 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹18.09 Cr (net margin 2.3%) and EBITDA of ₹25.85 Cr (EBITDA margin 3.3%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 22% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Abil Chempharma. As per MCA filings, the company has open charges of ₹67 Cr and satisfied charges of ₹79.07 Cr on record. Court records list 62 cases involving the company, including 44 filed by the company and 18 filed against it; 18 cases are pending. The company has 7 deals on record (5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.91 Cr; the latest was in April 2024. The company has 12 MSME Form 1 returns on record between 2018 and 2024, listing 417 overdue payments to 40 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website abilchempharma.in.
Company details
Contact details
Abil Chempharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is abilchempharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1701 17th Floor B – Wing Lotus Corporate Park Graham Firth Steel Comp. We Highway Gore, Goan East, Mumbai, Maharashtra, India – 400063
- IndustryPharma, API Manufacturers, Drug Formulation & Development, Pharmaceutical Retailers & Distributors
To see the full contact details of Abil Chempharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Abil Chempharma operates one associated brand: Abil Chempharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing, marketing, and exporting of APIs, intermediates, and finished formulations in the pharmaceutical sector. | abilchempharma.in |
Business activity
The main business activity of Abil Chempharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Abil Chempharma Private Limited, buy the company report.
Financials of Abil Chempharma Private Limited
FY 2025 filings availableAbil Chempharma Private Limited reported revenue of ₹795.2 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 6% growth in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹795.2 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25.85 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18.09 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Abil Chempharma Private Limited, buy the company report.
Board of directors of Abil Chempharma Private Limited
Abil Chempharma has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanket Jatin Gandhi | Director | 21 Aug 2023 | 3 Years 2 Months | Current |
| Tejas Champaklal Shah | Director | 01 Dec 2012 | 13 Years 10 Months | Current |
| Jayesh Ajit Paurana | Additional Director | 08 Apr 2026 | 0 Years 6 Months | Current |
Auditor
Abil Chempharma Private Limited is audited by Parikh and Amin Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Parikh and Amin Associates | FY 2023 | 107520W |
Shareholding
The shareholding of Abil Chempharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Abil Chempharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Aug 2025 | 101151892 | Axis Bank Limited | ₹22 Cr | Open | |
| 20 Jul 2018 | 100212496 | Axis Bank Limited | ₹45 Cr | Open | |
| 25 Nov 2022 | 100645273 | Others | ₹12.5 Cr | Satisfied | |
| 30 Oct 2021 | 100502219 | State Bank of India | ₹4.95 Cr | Satisfied | |
| 03 Mar 2021 | 100424092 | Others | ₹5.62 Cr | Satisfied |
To see the full charge records of Abil Chempharma Private Limited, buy the company report.
Total charge records: 9 View all charges
Deals & funding
Abil Chempharma Private Limited has 7 deals on record (5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.91 Cr; the latest was in April 2024.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2024 | Secondary share transfer | Undisclosed | Seller: 2 individuals |
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2013 | Funding round | ₹1.76 Cr | Investors: an individual |
| Mar 2011 | Funding round | ₹15 Lakh | Investors: an individual |
To see the full deal history of Abil Chempharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Abil Chempharma Private Limited has 62 court cases on record: 44 filed by Abil Chempharma, 18 filed against it. 18 cases are pending and 44 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 53 | 9 | 14 |
| High courts | 9 | 9 | 4 |
Cases on record (5 of 62)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Themis Medicare Ltd | Pending |
| District court, Thane, Maharashtra | Commercial suit | Filed by the company against Alps Communication Pvt. Ltd. | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed by the company against M/S Globofarm LLP | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Cri.Appeal) | Filed against the company by Vexta Laboratories Pvt. Ltd.(48Th M M Court, Andheri, Mumbai) and 1 other | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed by the company against M/S Globofarm LLP and 2 others | Pending |
To see the full case history of Abil Chempharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Abil Chempharma Private Limited has 12 MSME Form 1 returns on record between 2018 and 2024, listing 417 overdue payments to 40 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 40)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sriam Labs Private Limited | |||
| Bhavi Traders | |||
| Signature Phytochemical Industries | |||
| Khandelwal Laboratories Pvt. Ltd. | |||
| Smilax Laboratories Limited |
To see the full MSME payment records of Abil Chempharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Abil Chempharma Private Limited has a workforce of 3 employees on its EPFO records as of Oct 09, 2025, across 1 active EPFO establishment.
GST
Abil Chempharma has 5 GST registrations: 2 active and 3 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECA1503D1ZE | Maharashtra | Active | 01 Jul 2017 |
| 06AAECA1503D1ZI | Haryana | Active | 04 Nov 2021 |
To see the full GST registrations and return filing status of Abil Chempharma Private Limited, buy the company report.
Recent activity
Abil Chempharma Private Limited has 11 board changes on record since 2010: 3 appointments and 8 cessations. The latest: Jayesh Ajit Paurana was appointed as Additional Director on 08 Apr 2026.
23 earlier events are in the company report.
Frequently asked questions
Abil Chempharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 18 September 2002 (24+ years old) and is registered under CIN U51397MH2002PTC137264.
Abil Chempharma has 3 current directors:
- Sanket Jatin Gandhi - Director
- Tejas Champaklal Shah - Director
- Jayesh Ajit Paurana - Additional Director
The latest financial statements of Abil Chempharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Abil Chempharma is 27AAECA1503D1ZE, registered in Maharashtra. The company has 5 GST registrations in all, of which 2 are active and 3 are cancelled or inactive. Other active GSTINs include 06AAECA1503D1ZI (Haryana).
The CIN (Corporate Identification Number) of Abil Chempharma is U51397MH2002PTC137264. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Abil Chempharma has 62 court cases on record: 44 filed by the company and 18 filed against it. 18 are pending. Most are in the district courts.
Abil Chempharma was incorporated on 18 September 2002, making it 24+ years old. It is registered with the Registrar of Companies, Mumbai.
Abil Chempharma has 7 deals on record (5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.91 Cr; the latest was in April 2024.
Jayesh Ajit Paurana was appointed as Additional Director on 08 Apr 2026. Nirav Vikram Maniar ceased to be Director on 10 Apr 2024. Sanket Jatin Gandhi was appointed as Director on 21 Aug 2023. Abil Chempharma has 11 board changes on record in total.
Abil Chempharma has 12 MSME Form 1 returns on record between 2018 and 2024, listing 417 overdue payments to 40 micro and small suppliers. The latest return was filed on 01 May 2024.
Abil Chempharma can be reached through the website abilchempharma.in. Its registered office is in Mumbai, Maharashtra, India.